Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tyco sees global prospects in $3.1 billion Bard deal

This article was originally published in Clinica

Executive Summary

Tyco International, owner of significant brand names in the device industry such as US Surgical and Mallinckrodt, is to become the largest company in the market following its agreed bid to purchase CR Bard for $3.1 billion in shares. Bard made sales of $1.1 billion in 2000, with Tyco turning over some $6.5 billion from healthcare activities to September 2000. It closed the acquisition of $2.5 billion turnover company Mallinckrodt after the end of the financial year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT071486

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel